Kinetics of di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate in blood and of DEHP metabolites in urine of male volunteers after single ingestion of ring-deuterated DEHP

Toxicology and Applied Pharmacology

Volumn 264, Issue 2, 2012, Pages 284-291

  Kessler, Winfried ^a   Numtip, Wanwiwa ^a   Völkel, Wolfgang ^b   Seckin, Elcim ^b   Csanády, György A ^a,c   Pütz, Christian ^a   Klein, Dominik ^a,c   Fromme, Hermann ^b   Filser, Johannes G ^a,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Bavarian Health and Food Safety Authority   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Blood; Di(2 ethylhexyl) phthalate (DEHP); Mono(2 ethylhexyl) phthalate (MEHP); Monoesters human; Urine

Indexed keywords

PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

ADULT; ARTICLE; BIOAVAILABILITY; BLOOD ANALYSIS; BODY WEIGHT; CALLITRICHINAE; CONCENTRATION (PARAMETERS); EXPERIMENTAL RAT; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MALE; METABOLITE; NORMAL HUMAN; RISK ASSESSMENT; TANDEM MASS SPECTROMETRY; TOXICITY TESTING; URINALYSIS;

ADULT; AREA UNDER CURVE; BIOTRANSFORMATION; BODY WEIGHT; DEUTERIUM; DIETHYLHEXYL PHTHALATE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCURONIDES; HALF-LIFE; HUMANS; INDICATORS AND REAGENTS; KINETICS; MALE; MIDDLE AGED;

MARMOSETS; RATTUS;

EID: 84866856208     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.08.009     Document Type: Article

References (43)

1. Akingbemi B.T., Youker R.T., Sottas C.M., Ge R., Katz E., Klinefelter G.R., Zirkin B.R., Hardy M.P. Modulation of rat Leydig cell steroidogenic function by di(2-ethylhexyl)phthalate. Biol. Reprod. 2001, 65:1252-1259.
2. Albro P.W. Metabolism of di(2-ethylhexyl)phthalate. Drug Metab. Rev. 1989, 21:13-34.
3. Albro P.W., Thomas R.O. Enzymatic hydrolysis of di-(2-ethylhexyl)phthalate by lipases. Biochim. Biophys. Acta 1973, 306:380-390.
4. Anderson W.A., Castle L., Hird S., Jeffery J., Scotter M.J. A twenty-volunteer study using deuterium labelling to determine the kinetics and fractional excretion of primary and secondary urinary metabolites of di-2-ethylhexylphthalate and di-iso-nonylphthalate. Food Chem. Toxicol. 2011, 49:2022-2029.
5. Brown R.P., Delp M.D., Lindstedt S.L., Rhomberg L.R., Beliles R.P. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 1997, 13:407-484.
6. Carrière F., Barrowman J.A., Verger R., Laugier R. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 1993, 105:876-888.
7. Chauvigné F., Menuet A., Lesné L., Chagnon M.C., Chevrier C., Régnier J.F., Angerer J., Jégou B. Time- and dose-related effects of di-(2-ethylhexyl) phthalate and its main metabolites on the function of the rat fetal testis in vitro. Environ. Health Perspect. 2009, 117:515-521.
8. Desdoits-Lethimonier C., Albert O., Le Bizec B., Perdu E., Zalko D., Courant F., Lesné L., Guillé F., Dejucq-Rainsford N., Jégou B. Human testis steroidogenesis is inhibited by phthalates. Hum. Reprod. 2012, 27:1451-1459.
9. European Union Risk Assessment Report Bis(2-ethylhexyl) Phthalate (DEHP) 2008, 2nd Priority List Vol. 80.
10. Fromme H., Albrecht M., Angerer J., Drexler H., Gruber L., Schlummer M., Parlar H., Körner W., Wanner A., Heitmann D., Roscher E., Bolte G. Integrated Exposure Assessment Survey (INES) exposure to persistent and bioaccumulative chemicals in Bavaria, Germany. Int. J. Hyg. Environ. Health 2007, 210:345-349.
11. Gentry P.R., Clewell H.J., Clewell R., Campbell J., Van Landingham C., Shipp A.M. Challenges in the application of quantitative approaches in risk assessment: a case study with di-(2-ethylhexyl)phthalate. Crit. Rev. Toxicol. 2011, 41(Suppl. 2):1-72.
12. Griffiths W.C., Camara P.D., Saritelli A., Gentile J. The in vitro serum protein-binding characteristics of bis-(2-ethylhexyl) phthalate and its principal metabolite, mono-(2-ethylhexyl) phthalate. Environ. Health Perspect. 1988, 77:151-156.
13. Guo Y., Alomirah H., Cho H.S., Minh T.B., Mohd M.A., Nakata H., Kannan K. Occurrence of phthalate metabolites in human urine from several Asian countries. Environ. Sci. Technol. 2011, 45:3138-3144.
14. Guo Y., Wu Q., Kannan K. Phthalate metabolites in urine from China, and implications for human exposures. Environ. Int. 2011, 37:893-898.
15. Hines C.J., Hopf N.B., Deddens J.A., Silva M.J., Calafat A.M. Estimated daily intake of phthalates in occupationally exposed groups. J. Exp. Sci. Environ. Epidemiol. 2011, 21:133-141.
16. Howdeshell K.L., Wilson V.S., Furr J., Lambright C.R., Rider C.V., Blystone C.R., Hotchkiss A.K., Gray L.E. A mixture of five phthalate esters inhibits fetal testicular testosterone production in the Sprague-Dawley rat in a cumulative, dose-additive manner. Toxicol. Sci. 2008, 105:153-165.
17. Ito Y., Yokota H., Wang R., Yamanoshita O., Ichihara G., Wang H., Kurata Y., Takagi K., Nakajima T. Species differences in the metabolism of di(2-ethylhexyl) phthalate (DEHP) in several organs of mice, rats, and marmosets. Arch. Toxicol. 2005, 79:147-154.
18. Kato K., Silva M.J., Brock J.W., Reidy J.A., Malek N.A., Hodge C.C., Nakazawa H., Needham L.L., Barr D.B. Quantitative detection of nine phthalate metabolites in human serum using reversed-phase high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. J. Anal. Toxicol. 2003, 27:284-289.
19. Kato K., Silva M.J., Reidy J.A., Hurtz D., Malek N.A., Needham L.L., Nakazawa H., Barr D.B., Calafat A.M. Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. Environ. Health Perspect. 2004, 112:327-330.
20. Kessler W., Phokha W., Csanády G.A., Filser J.G. No background concentrations of di(2-ethylhexyl) phthalate and mono(2-ethylhexyl) phthalate in blood of rats. Arch. Toxicol. 2001, 75:62-64.
21. Kessler W., Numtip W., Grote K., Csanády G.A., Chahoud I., Filser J.G. Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono(2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets. Toxicol. Appl. Pharmacol. 2004, 195:142-153.
22. Koch H.M., Bolt H.M., Angerer J. Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and plasma after a single oral dose of deuterium-labelled DEHP. Arch. Toxicol. 2004, 78:123-130.
23. Koch H.M., Bolt H.M., Preuss R., Angerer J. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and plasma after single oral doses of deuterium-labelled DEHP. Arch. Toxicol. 2005, 79:367-376.
24. Koch H.M., Preuss R., Angerer J. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure - an update and latest results. Int. J. Androl. 2006, 29:155-165.
25. Koch H.M., Wittassek M., Brüning T., Angerer J., Heudorf U. Exposure to phthalates in 5-6years old primary school starters in Germany-a human biomonitoring study and a cumulative risk assessment. Int. J. Hyg. Environ. Health 2011, 214:188-195.
26. Kurata Y., Kidachi F., Yokoyama M., Toyota N., Tsuchitani M., Katoh M. Subchronic toxicity of di(2-ethylhexyl)phthalate in common marmosets: lack of hepatic peroxisome proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia. Toxicol. Sci. 1998, 42:49-56.
27. Kurata Y., Shimamura N., Katoh M. Metabolite profiling and identification in human urine after single oral administration of DEHP. J. Toxicol. Sci. 2012, 7:401-414.
28. Laguë E., Tremblay J.J. Antagonistic effects of testosterone and the endocrine disruptor mono-(2-ethylhexyl) phthalate on INSL3 transcription in Leydig cells. Endocrinology 2008, 149:4688-4694.
29. Li H., Kim K.H. Effects of mono-(2-ethylhexyl) phthalate on fetal and neonatal rat testis organ cultures. Biol. Reprod. 2003, 69:1964-1972.
30. Lin S., Ku H.Y., Su P.H., Chen J.W., Huang P.C., Angerer J., Wang S.L. Phthalate exposure in pregnant women and their children in central Taiwan. Chemosphere 2011, 82:947-955.
31. Lindena J., Küpper W., Trautschold I. Catalytic enzyme activity concentration in thoracic duct, liver, and intestinal lymph of the dog, the rabbit, the rat and the mouse. Approach to a quantitative diagnostic enzymology, II. Communication. J. Clin. Chem. Clin. Biochem. 1986, 24:19-33.
32. Lorber M., Koch H., Angerer J. A critical evaluation of the creatinine correction approach: Can it underestimate intakes of phthalates? A case study with di-2-ethylhexyl phthalate. Supplementary evaluations and data. J. Exp. Sci. Environ. Epidemiol. 2011, 21:576-586.
33. Marsee K., Woodruff T.J., Axelrad D.A., Calafat A.M., Swan S.H. Estimated daily phthalate exposures in a population of mothers of male infants exhibiting reduced anogenital distance. Environ. Health Perspect. 2006, 114:805-809.
34. Pan G., Hanaoka T., Yoshimura M., Zhang S., Wang P., Tsukino H., Inoue K., Nakazawa H., Tsugane S., Takahashi K. Decreased serum free testosterone in workers exposed to high levels of di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP): a cross-sectional study in China. Environ. Health Perspect. 2006, 114:1643-1648.
35. Preau J.L., Wong L.Y., Silva M.J., Needham L.L., Calafat A.M. Variability over 1week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study. Environ. Health Perspect. 2010, 118:1748-1754.
36. Samandar E., Silva M.J., Reidy J.A., Needham L.L., Calafat A.M. Temporal stability of eight phthalate metabolites and their glucuronide conjugates in human urine. Environ. Res. 2009, 109:641-646.
37. Seckin E., Fromme H., Völkel W. Determination of total and free mono-n-butyl phthalate in human urine samples after medication of a di-n-butyl phthalate containing capsule. Toxicol. Lett. 2009, 188:33-37.
38. Silva M.J., Preau J.L., Needham L.L., Calafat A.M. Cross validation and ruggedness testing of analytical methods used for the quantification of urinary phthalate metabolites. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 873:180-186.
39. Takatori S., Kitagawa Y., Kitagawa M., Nakazawa H., Hori S. Determination of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate in human serum using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 804:397-401.
40. Thews G., Mutschler E., Vaupel P. Anatomie, Physiologie, Pathophysiologie des Menschen 1991, Wissenschaftliche Verlagsgesellschaft, Stuttgart. 4th Auflage.
41. Tomonari Y., Kurata Y., David R.M., Gans G., Kawasuso T., Katoh M. Effect of di(2-ethylhexyl) phthalate (DEHP) on genital organs from juvenile common marmosets: I. Morphological and biochemical investigation in 65-week toxicity study. J. Toxicol. Environ. Health A 2006, 69:1651-1672.
42. Wittassek M., Heger W., Koch H.M., Becker K., Angerer J., Kolossa-Gehring M. Daily intake of di(2-ethylhexyl)phthalate (DEHP) by German children - A comparison of two estimation models based on urinary DEHP metabolite levels. Int. J. Hyg. Environ. Health 2007, 210:35-42.
43. Wittassek M., Koch H.M., Angerer J., Brüning T. Assessing exposure to phthalates - the human biomonitoring approach. Mol. Nutr. Food Res. 2011, 55:7-31.